$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000143774919022921 Filed on November 14, 2019

Income Statement

Concept	2019 Q3	2018 Q3
Revenue	$1.900M	$1.622M
YoY Change	17.11%	-43.16%
Cost Of Revenue	$523.7K	$1.742M
YoY Change	-69.95%	66.82%
Gross Profit	$1.376M	-$120.2K
YoY Change	-1244.84%	-106.64%
Gross Profit Margin	72.44%	-7.41%
Selling, General & Admin	$2.315M	$2.886M
YoY Change	-19.79%	-9.98%
% of Gross Profit	168.22%
Research & Development	$7.940K	$1.500K
YoY Change	429.33%	-91.12%
% of Gross Profit	0.58%
Depreciation & Amortization	$25.42K	$345.0K
YoY Change	-92.63%	109.25%
% of Gross Profit	1.85%
Operating Expenses	$2.323M	$4.427M
YoY Change	-47.53%	37.37%
Operating Profit	-$946.7K	-$4.548M
YoY Change	-79.18%	221.7%
Interest Expense	-$1.899M	$1.540K
YoY Change	-123431.17%
% of Operating Profit
Other Income/Expense, Net	-$2.633K	-$1.784K
YoY Change	47.59%	70.55%
Pretax Income	-$2.849M	-$4.548M
YoY Change	-37.36%	222.3%
Income Tax	$1.250K	$1.622K
% Of Pretax Income
Net Earnings	-$2.837M	-$4.393M
YoY Change	-35.42%	211.34%
Net Earnings / Revenue	-149.33%	-270.79%
Basic Earnings Per Share	-$0.06	-$0.12
Diluted Earnings Per Share	-$0.06	-$0.12
COMMON SHARES
Basic Shares Outstanding	47.72M	35.59M
Diluted Shares Outstanding	47.72M	35.59M

Balance Sheet

Concept	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.711M	$414.8K
YoY Change	312.52%	-82.04%
Cash & Equivalents	$1.711M	$414.8K
Short-Term Investments
Other Short-Term Assets	$559.7K	$1.236M
YoY Change	-54.73%	35.87%
Inventory	$1.617M	$2.246M
Prepaid Expenses
Receivables	$1.239M	$1.014M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.756M	$7.055M
YoY Change	-18.42%	-39.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$55.31K	$94.59K
YoY Change	-41.52%	-21.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$35.91K	$26.88K
YoY Change	33.59%	0.0%
Total Long-Term Assets	$486.7K	$570.0K
YoY Change	-14.61%	-85.57%
TOTAL ASSETS
Total Short-Term Assets	$5.756M	$7.055M
Total Long-Term Assets	$486.7K	$570.0K
Total Assets	$6.243M	$7.625M
YoY Change	-18.13%	-50.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$739.7K	$1.307M
YoY Change	-43.38%	112.09%
Accrued Expenses	$698.8K	$2.003M
YoY Change	-65.11%	-7.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.647M	$6.579M
YoY Change	16.23%	30.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.647M	$6.579M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$7.647M	$6.579M
YoY Change	16.23%	1.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$90.66M	-$86.18M
YoY Change	5.2%	12.24%
Common Stock	$90.21M	$88.01M
YoY Change	2.51%	1.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	-$1.358M	$915.6K
YoY Change
Total Liabilities & Shareholders Equity	$6.243M	$7.625M
YoY Change	-18.13%	-50.94%

Cashflow Statement

Concept	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$2.837M	-$4.393M
YoY Change	-35.42%	211.34%
Depreciation, Depletion And Amortization	$25.42K	$345.0K
YoY Change	-92.63%	109.25%
Cash From Operating Activities	-$653.4K	-$437.6K
YoY Change	49.32%	-28.26%
INVESTING ACTIVITIES
Capital Expenditures	-$1.820K	-$6.510K
YoY Change	-72.04%	-95.93%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$1.820K	-$14.53K
YoY Change	-87.47%	-90.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	28.87K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-653.4K	-437.6K
Cash From Investing Activities	-1.820K	-14.53K
Cash From Financing Activities	28.87K	0.000
Net Change In Cash	-626.4K	-452.1K
YoY Change	38.54%	-30.44%
FREE CASH FLOW
Cash From Operating Activities	-$653.4K	-$437.6K
Capital Expenditures	-$1.820K	-$6.510K
Free Cash Flow	-$651.6K	-$431.1K
YoY Change	51.15%	-4.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q3	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1011244
CY2018Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	686798
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2019Q3	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	372700
CY2018Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	421800
CY2019Q3	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	598324
CY2018Q3	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1371085
	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	3900382
	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	3742737
CY2019Q3	mlss	Equity Securities Issued EquitySecuritiesIssued	5850000
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2018Q2	mlss	Adjustment To Equity Related To Asset Acquisition AdjustmentToEquityRelatedToAssetAcquisition	286602
	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	117121
	mlss	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	-57750
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.50
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2019Q3	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	2.6
	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces	151562
	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces
	mlss	Deferred Cost Reserve DeferredCostReserve
	mlss	Deferred Cost Reserve DeferredCostReserve	790189
CY2019Q3	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment
CY2018Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1539794
CY2019Q3	mlss	Gain Loss On Liability Classified Shares To Be Issued GainLossOnLiabilityClassifiedSharesToBeIssued	1200000
	mlss	Gain Loss On Liability Classified Shares To Be Issued GainLossOnLiabilityClassifiedSharesToBeIssued	2200000
CY2019Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2849917
CY2018Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4549443
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4745454
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7990188
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	1011245
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-43892
	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	117122
	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-20289
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	187631
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-166292
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	166292
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase
	mlss	Proceeds From Sale Of Variable Interest Entity Shares With Agreement To Repurchase ProceedsFromSaleOfVariableInterestEntitySharesWithAgreementToRepurchase	-250000
	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares
	mlss	Sale Of Variable Interest Entitys Shares SaleOfVariableInterestEntitysShares	-1400000
	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered	67000
	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	416500
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	350103
CY2019Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	61500
CY2019Q3	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	150000
CY2018Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	339500
CY2018Q2	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	60000
CY2018Q3	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	15000
CY2019Q2	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock
CY2019Q3	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	28875
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	37500
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	211500
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	47401
	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue	560199
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y127D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P76D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y109D
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	739726
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1059186
CY2019Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1553860
CY2018Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1810058
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1239261
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1978456
CY2019Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent
CY2018Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	100000
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	698790
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	794918
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	90166259
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	88414718
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44712
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45147
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86809
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	84092
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	76524
CY2019Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	628494
CY2018Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	648783
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39760
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	801426
CY2019Q3	us-gaap	Assets Assets	6242520
CY2018Q4	us-gaap	Assets Assets	6400968
CY2019Q3	us-gaap	Assets Current AssetsCurrent	5755787
CY2018Q4	us-gaap	Assets Current AssetsCurrent	5856260
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	414829
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	967820
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2222127
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q3	us-gaap	Cash Cash	1700000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	743429
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2636956
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1711249
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.49
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1592775
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3284196
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48199073
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33859034
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48165740
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33825701
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	48199
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	36330
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	523672
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1742451
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1894550
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3326341
CY2019Q3	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	0
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2470565
CY2019Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent
CY2018Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	50000
	us-gaap	Depreciation Depreciation	37159
	us-gaap	Depreciation Depreciation	53675
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25418
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	344984
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76919
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	855101
CY2019Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	3216127
CY2018Q4	us-gaap	Derivative Liabilities DerivativeLiabilities
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	18942323
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	15191493
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	423948
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	789957
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	983348
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	1888409
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	23477542
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	17696033
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-4535219
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-2504900
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	254192
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	920516
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1448594
	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	1907098
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	18942323
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	15191133
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-344132
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-450569
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-2451788
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-1835639
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	678140
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	1710473
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	2431942
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	3795507
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-109989
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	467352
CY2018Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1539794
CY2019Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1016639
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	982349
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2042443
CY2019Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4017510
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	395514
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	435273
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1846761
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1899484
CY2018Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q3	us-gaap	Gross Profit GrossProfit	1376149
CY2018Q3	us-gaap	Gross Profit GrossProfit	-120205
	us-gaap	Gross Profit GrossProfit	4179030
	us-gaap	Gross Profit GrossProfit	2530010
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1500000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1539794
CY2019Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2848667
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4547821
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4725577
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7973028
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49100
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	258616
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1250
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1622
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19877
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17160
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	184
CY2018Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1544
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1391
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6135
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-465670
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	328900
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-739195
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-521347
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-100000
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-466455
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-50424
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	859677
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-100000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-466455
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-50000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	470708
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-303989
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-405234
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	9027
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90362
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9854
CY2019Q3	us-gaap	Inventory Net InventoryNet	1617062
CY2018Q4	us-gaap	Inventory Net InventoryNet	1921051
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	763000
CY2019Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	752000
CY2019Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	81911
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	123918
	us-gaap	Inventory Write Down InventoryWriteDown
	us-gaap	Inventory Write Down InventoryWriteDown	728017
CY2019Q3	us-gaap	Lease Cost LeaseCost	39555
	us-gaap	Lease Cost LeaseCost	118664
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55531
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15976
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	39555
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	714
CY2019Q3	us-gaap	Liabilities Liabilities	7647264
CY2018Q4	us-gaap	Liabilities Liabilities	4872760
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6242520
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6400968
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7647264
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4872760
CY2019Q3	us-gaap	Minority Interest MinorityInterest	-46745
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-11402
CY2018Q3	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	8020
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2253422
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9916
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14525
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1275686
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1957602
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-2836976
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4392824
	us-gaap	Net Income Loss NetIncomeLoss	-4661012
	us-gaap	Net Income Loss NetIncomeLoss	-7611513
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12941
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11742
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35343
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-118424
CY2019Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	2322883
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	4427376
	us-gaap	Operating Expenses OperatingExpenses	7051779
	us-gaap	Operating Expenses OperatingExpenses	10503934
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-946734
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4547581
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2872749
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7973924
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	39555
	us-gaap	Operating Lease Cost OperatingLeaseCost	118664
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	166292
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	54817
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	54817
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
	us-gaap	Operating Lease Payments OperatingLeasePayments	118664
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166292
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54818
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P146D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	175557
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four And Five Years OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two And Three Years OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears	16419
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	159138
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35905
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26878
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2633
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1784
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7458
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5239
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	8020
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9916
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6505
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7000
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7000
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	7
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	504903
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414541
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassifications have been made to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> financial statements to conform to the condensed  consolidated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on net loss or cash flows as previously reported.</div></div></div></div></div></div></div></div></div></div></div></div></div></div>
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	28875
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1974547
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
	us-gaap	Profit Loss ProfitLoss	-4696358
	us-gaap	Profit Loss ProfitLoss	-7729937
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-1053243
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2849917
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-1975385
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-1349986
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-4404566
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55314
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82557
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7940
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1500
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109815
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	215655
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85999929
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-90660941
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1899821
CY2018Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1622246
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6073580
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5856351
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2314943
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2886082
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6941964
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8748485
	us-gaap	Share Based Compensation ShareBasedCompensation	146847
	us-gaap	Share Based Compensation ShareBasedCompensation	247425
CY2019Q3	us-gaap	Share Price SharePrice	0.83
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	37500
CY2018Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-1357999
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1539610
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	837432
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1404744
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7500628
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5951552
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5319509
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1045947
CY2019Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q3	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, valuation of derivative liabilities, and valuation allowances on deferred tax assets. Actual results could differ from those estimates<div style="display: inline; font-weight: bold;">.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding
CY2019Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	560199
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47721732
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35586995
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43311984
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35086822
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47721732
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35586995
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43311984
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35086822

Files In Submission

Name	View Source	Status
0001437749-19-022921-index-headers.html	Edgar Link	pending
0001437749-19-022921-index.html	Edgar Link	pending
0001437749-19-022921.txt	Edgar Link	pending
0001437749-19-022921-xbrl.zip	Edgar Link	pending
ex_156805.htm	Edgar Link	pending
ex_156806.htm	Edgar Link	pending
ex_156807.htm	Edgar Link	pending
ex_156808.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20190930.xml	Edgar Link	completed
mlss-20190930.xsd	Edgar Link	pending
mlss-20190930_cal.xml	Edgar Link	unprocessable
mlss-20190930_def.xml	Edgar Link	unprocessable
mlss-20190930_lab.xml	Edgar Link	unprocessable
mlss-20190930_pre.xml	Edgar Link	unprocessable
mlss20190930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q3 Form 10-Q Financial Statement

#000143774919022921 Filed on November 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q3 Form 10-Q Financial Statement

#000143774919022921 Filed on November 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss